Cited 0 times in
Robust Predictive Performance of the SALT-M Score for Clinical Outcomes in Asian Patients With Acute-on-Chronic Liver Failure
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김덕기 | - |
dc.contributor.author | 김명수 | - |
dc.contributor.author | 박준용 | - |
dc.contributor.author | 안상훈 | - |
dc.contributor.author | 이재근 | - |
dc.contributor.author | 이혜원 | - |
dc.contributor.author | 임승혁 | - |
dc.contributor.author | 주동진 | - |
dc.date.accessioned | 2025-02-03T08:30:01Z | - |
dc.date.available | 2025-02-03T08:30:01Z | - |
dc.date.issued | 2025-01-01 | - |
dc.identifier.issn | 0269-2813 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/201708 | - |
dc.description.abstract | Background: Acute-on-chronic liver failure (ACLF) is a syndrome of patients with chronic liver disease presenting with multiple organ failures. Recently, Sundaram-ACLF-LT Mortality (SALT-M) score has been developed to predict 1-year post-liver transplantation mortality. We validated the SALT-M score in a large-volume, Asian single-centre cohort. Aims: We validated the SALT-M score in a large-volume, Asian single-centre cohort. Methods: We analysed 224 patients of ACLF grade 2-3. Area under the receiver operating characteristic curve (AUROC) and concordance index (c-index) were used to assess and compare the predictability of posttransplant mortality of SALT-M and other scores. Moreover, we compared the survivals of patients with high and low SALT-M, in conjunction with MELD score and ACLF grade. Results: The AUROC for prediction of 1-year post-LT survival was higher in SALT-M (0.691) than in MELD, MELD-Na, MELD 3.0 and delta-MELD. Similarly, the c-index of the SALT-M (0.650) was higher than aforementioned MELD systems. When categorised by the cut-off of SALT-M ≥ 20 and MELD ≥ 30, patients with high SALT-M exhibited lower post-LT survival than those with low SALT-M scores regardless of high or low MELD (40.0% for high SALT-M/high MELD vs. 42.9% for high SALT-M/low MELD vs. 73.8% for low SALT-M/high MELD vs. 63.7% for low SALT-M/low MELD, p < 0.001). In patients with ACLF grade 3, SALT-M effectively stratified the posttransplant mortality (39.4% for high SALT-M vs. 63.1% for low SALT-M, p = 0.018). Conclusions: SALT-M outperformed previous MELD systems for predicting posttransplant mortality in Asian LT cohort with severe ACLF. Transplantability for patients with severe ACLF could be determined based on SALT-M. | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | Wiley-Blackwell | - |
dc.relation.isPartOf | ALIMENTARY PHARMACOLOGY & THERAPEUTICS | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.subject.MESH | Acute-On-Chronic Liver Failure* / mortality | - |
dc.subject.MESH | Adult | - |
dc.subject.MESH | Asian People | - |
dc.subject.MESH | Cohort Studies | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Liver Transplantation* | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Predictive Value of Tests | - |
dc.subject.MESH | Prognosis | - |
dc.subject.MESH | ROC Curve | - |
dc.subject.MESH | Retrospective Studies | - |
dc.subject.MESH | Severity of Illness Index | - |
dc.title | Robust Predictive Performance of the SALT-M Score for Clinical Outcomes in Asian Patients With Acute-on-Chronic Liver Failure | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Surgery (외과학교실) | - |
dc.contributor.googleauthor | Kunhee Kim | - |
dc.contributor.googleauthor | Seung Hyuk Yim | - |
dc.contributor.googleauthor | Jae Geun Lee | - |
dc.contributor.googleauthor | Dong Jin Joo | - |
dc.contributor.googleauthor | Myoung Soo Kim | - |
dc.contributor.googleauthor | Jun Yong Park | - |
dc.contributor.googleauthor | Sang Hoon Ahn | - |
dc.contributor.googleauthor | Deok-Gie Kim | - |
dc.contributor.googleauthor | Hye Won Lee | - |
dc.identifier.doi | 10.1111/apt.18335 | - |
dc.contributor.localId | A05303 | - |
dc.contributor.localId | A00424 | - |
dc.contributor.localId | A01675 | - |
dc.contributor.localId | A02226 | - |
dc.contributor.localId | A03068 | - |
dc.contributor.localId | A03318 | - |
dc.contributor.localId | A06254 | - |
dc.contributor.localId | A03948 | - |
dc.relation.journalcode | J00061 | - |
dc.identifier.eissn | 1365-2036 | - |
dc.identifier.pmid | 39392334 | - |
dc.identifier.url | https://onlinelibrary.wiley.com/doi/10.1111/apt.18335 | - |
dc.subject.keyword | Asian | - |
dc.subject.keyword | SALT‐M score | - |
dc.subject.keyword | acute‐on‐chronic liver failure | - |
dc.subject.keyword | liver transplantation | - |
dc.contributor.alternativeName | Kim, Deok Gie | - |
dc.contributor.affiliatedAuthor | 김덕기 | - |
dc.contributor.affiliatedAuthor | 김명수 | - |
dc.contributor.affiliatedAuthor | 박준용 | - |
dc.contributor.affiliatedAuthor | 안상훈 | - |
dc.contributor.affiliatedAuthor | 이재근 | - |
dc.contributor.affiliatedAuthor | 이혜원 | - |
dc.contributor.affiliatedAuthor | 임승혁 | - |
dc.contributor.affiliatedAuthor | 주동진 | - |
dc.citation.volume | 61 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 168 | - |
dc.citation.endPage | 176 | - |
dc.identifier.bibliographicCitation | ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.61(1) : 168-176, 2025-01-01 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.